Series C - Elixir Pharmaceuticals - Nov 27, 2006 Funding Round Profile - Cointime

Bitcoin $79,067.56 +3.12%
Ethereum $3,175.25 +3.94%
BNB $628.56 -0.70%
Optimism $1.66 -0.98%
Arbitrum $0.62 +1.31%
Solana $206.02 +1.85%
Polygon $0.40 +3.49%
Cosmos $4.94 +3.45%
Avalanche $31.64 +6.71%

Bitcoin $79,067.56 +3.12%
Ethereum $3,175.25 +3.94%
BNB $628.56 -0.70%
Optimism $1.66 -0.98%
Arbitrum $0.62 +1.31%
Solana $206.02 +1.85%
Polygon $0.40 +3.49%
Cosmos $4.94 +3.45%
Avalanche $31.64 +6.71%

Elixir Pharmaceuticals

company

Funding Round

Series C

Money Raised

$ 31M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Hercules Capital	-	-	-	Detail
ARCH Venture Partners	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Oct 13, 2003	Series B	$ 40.50M	ARCH Venture Partners	Detail